Health Technology Assessment: Lessons Learned from Around the World-An Overview

被引：62
作者：
O'Donnell, John C. [1 ]
Pham, Sissi V. [2 ]
Pashos, Chris L. [3 ]
Miller, David W. [4 ]
Smith, Marilyn Dix [5 ]
机构：
[1] Bristol Myers Squibb Co, Global Hlth Outcomes, Princeton, NJ 08543 USA
[2] Sissi Pham Consulting Inc, Chapel Hill, NC USA
[3] Abt Biopharm Solut Inc, Lexington, MA USA
[4] Miller Pharma Consulting, London, England
[5] ISPOR, Lawrenceville, NJ USA
来源：
VALUE IN HEALTH | 2009年 / 12卷
关键词：
comparative effectiveness; evidence-based medicine; health technology assessment; HTA; EVIDENCE-BASED MEDICINE; HYPERTENSION; NICE;
D O I：
10.1111/j.1524-4733.2009.00550.x
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
[No abstract available]
引用
收藏
页码：S1 / S5
页数：5
相关论文
共 29 条
[1]  
*AETMIS, AG BACKGR
[2]  
Australian-Government, PBS
[3]  
*CAN AG DRUGS TECH, CCOHTA CADTH OUR HIS
[4]   Yes No" or "Yes, but"? Multinomial modelling of NICE decision-making [J].
Dakin, Helen Angela ;
Devlin, Nancy J. ;
Odeyemi, Isaac A. O. .
HEALTH POLICY, 2006, 77 (03) :352-367
[5]   Does NICE have a cost-effectiveness threshold and what other factors influence its decisions? A binary choice analysis [J].
Devlin, N ;
Parkin, D .
HEALTH ECONOMICS, 2004, 13 (05) :437-452
[6]  
*ECRI, ECRI I HIST
[7]   Evidence-based medicine: A unified approach [J].
Eddy, DM .
HEALTH AFFAIRS, 2005, 24 (01) :9-17
[8]  
*FDN MAN CAR PHARM, AMCP FORM FORM SUBM
[9]   Economic implications of evidence-based prescribing for hypertension - Can better care cost less? [J].
Fischer, MA ;
Avorn, J .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 291 (15) :1850-1856
[10]  
Goodman C., 2004, HTA 101 INTRO HLTH T
123